Pipeline Brief
One concise weekly view of stage changes, readouts, catalysts, and deals—each with direct source links.
The Pipeline Brief is our weekly email for biotech operators, investors, analysts, and scientists who need to track peptide therapeutics without the hype.
- Verified stage changes with source links
- Readout summaries with missing-context caveats
- Catalyst calendar updates
- Notable deals and sponsor changes
- Methodology and data notes